checkAd

    DGAP-News  1068  0 Kommentare Geratherm Medical AG: New SRA Technology detects atrial fibrillation at an early stage and prevents strokes - Seite 2


    The free access publication of the study with the title "Improved detection
    of paroxysmal atrial fibrillation utilizing a software-assisted
    electrocardiogram approach" is available at:
    http://apoplexmedical.com/index.php/en/news/studie

    About apoplex medical technologies
    apoplex medical technologies GmbH was founded in 2004 in Pirmasens, in the
    west of the Rhineland-Palatinate, and, within the field of medical
    technology, specializes in new and innovative technological products for
    the prevention of strokes throughout the world. The subsidiary of Geratherm
    Medical AG focuses on easily applicable and efficient methods of patient
    screening using medical-technical applications to prevent strokes and
    vascular dementia. The SRA (Stroke Risk Analysis) procedure is the first
    practicable screening method for paroxysmal atrial fibrillation. It is
    available in versions for use in medical practices and stroke units.
    apoplex medical technologies is supported by an extensive academic and
    clinical network, which professionally supplements its own core competences
    in the fields of mathematics, physics and medicine. Further information is
    available at www.apoplexmedical.com.

    Further information
    apoplex medical technologies GmbH
    Albert Hirtz
    Delaware Avenue 1 - 3
    D-66953 Pirmasens
    fon: +49/(0)6331/698998-0
    fax: +49/(0)6331/698998-19
    http://www.apoplexmedical.com
    a.hirtz@apoplexmedical.com


    End of Corporate News

    ---------------------------------------------------------------------

    03.03.2014 Dissemination of a Corporate News, transmitted by DGAP - a
    company of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    DGAP's Distribution Services include Regulatory Announcements,
    Financial/Corporate News and Press Releases.
    Media archive at www.dgap-medientreff.de and www.dgap.de

    ---------------------------------------------------------------------


    Language: English
    Company: Geratherm Medical AG
    Fahrenheitstraße 1
    98716 Geschwenda
    Germany
    Phone: +49 (0)36205 98-0
    Fax: +49 (0)36205 98-1 15
    E-mail: info@geratherm.com
    Internet: www.geratherm.com
    ISIN: DE0005495626
    WKN: 549562
    Listed: Regulierter Markt in Frankfurt (Prime Standard);
    Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
    Stuttgart


    End of News DGAP News-Service
    ---------------------------------------------------------------------
    255329 03.03.2014
    Seite 2 von 2


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News Geratherm Medical AG: New SRA Technology detects atrial fibrillation at an early stage and prevents strokes - Seite 2 DGAP-News: Geratherm Medical AG / Key word(s): Study Geratherm Medical AG: New SRA Technology detects atrial fibrillation at an early stage and prevents strokes 03.03.2014 / 09:28 --------------------------------------------------------------------- …

    Schreibe Deinen Kommentar

    Disclaimer